Ziliang Cheng1,2, Zhuo Wu1,2, Guangzi Shi1, Zhilong Yi1, Mingwei Xie1, Weike Zeng1, Chao Song1, Chushan Zheng1, Jun Shen3,4. 1. Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, No. 107 Yanjiang Road West, Guangzhou, Guangdong, 510120, China. 2. Guangdong Provincial Key Laboratory of Malignant Tumour Epigenetics and Gene Regulation, Medical Research Centre, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. 3. Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, No. 107 Yanjiang Road West, Guangzhou, Guangdong, 510120, China. shenjun@mail.sysu.edu.cn. 4. Guangdong Provincial Key Laboratory of Malignant Tumour Epigenetics and Gene Regulation, Medical Research Centre, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. shenjun@mail.sysu.edu.cn.
Abstract
OBJECTIVE: To determine the diagnostic performance of volumetric quantitative dynamic contrast-enhanced MRI (qDCE-MRI) in differentiation between malignant and benign breast lesions. METHODS: DCE-MRI was performed in 124 patients with 136 breast lesions. Quantitative pharmacokinetic parameters Ktrans, Kep, Ve, Vp and semi-quantitative parameters TTP, MaxCon, MaxSlope, AUC were obtained by using a two-compartment extended Tofts model and three-dimensional volume of interest. Morphologic features (lesion size, margin, internal enhancement pattern) and time-signal intensity curve (TIC) type were also assessed. Logistic regression analysis was used to determine predictors of malignancy, followed by receiver operating characteristics (ROC) analysis to evaluate the diagnostic performance. RESULTS: qDCE parameters (Ktrans, Kep, Vp, TTP, MaxCon, MaxSlope and AUC), morphological parameters and TIC type were significantly different between malignant and benign lesions (P≤0.001). Multivariate logistic regression analyses showed that Ktrans, Kep, MaxSlope, size, margin and TIC type were independent predictors of malignancy. The diagnostic accuracy of logistic models based on qDCE parameters alone, morphological features plus TIC type, and all parameters combined was 94.9%, 89.0%, and 95.6% respectively. CONCLUSION: qDCE-MRI can be used to improve diagnostic differentiation between benign and malignant breast lesions in relation to morphology and kinetic analysis. KEY POINTS: • qDCE-MRI parameters are useful for discriminating between malignant and benign breast lesions. • K trans , K ep and MaxSlope were independent predictors of breast malignancy. • qDCE-MRI has a better diagnostic ability than morphology and kinetic analysis. • qDCE-MRI can be used to improve the diagnostic accuracy of breast malignancy.
OBJECTIVE: To determine the diagnostic performance of volumetric quantitative dynamic contrast-enhanced MRI (qDCE-MRI) in differentiation between malignant and benign breast lesions. METHODS: DCE-MRI was performed in 124 patients with 136 breast lesions. Quantitative pharmacokinetic parameters Ktrans, Kep, Ve, Vp and semi-quantitative parameters TTP, MaxCon, MaxSlope, AUC were obtained by using a two-compartment extended Tofts model and three-dimensional volume of interest. Morphologic features (lesion size, margin, internal enhancement pattern) and time-signal intensity curve (TIC) type were also assessed. Logistic regression analysis was used to determine predictors of malignancy, followed by receiver operating characteristics (ROC) analysis to evaluate the diagnostic performance. RESULTS: qDCE parameters (Ktrans, Kep, Vp, TTP, MaxCon, MaxSlope and AUC), morphological parameters and TIC type were significantly different between malignant and benign lesions (P≤0.001). Multivariate logistic regression analyses showed that Ktrans, Kep, MaxSlope, size, margin and TIC type were independent predictors of malignancy. The diagnostic accuracy of logistic models based on qDCE parameters alone, morphological features plus TIC type, and all parameters combined was 94.9%, 89.0%, and 95.6% respectively. CONCLUSION: qDCE-MRI can be used to improve diagnostic differentiation between benign and malignant breast lesions in relation to morphology and kinetic analysis. KEY POINTS: • qDCE-MRI parameters are useful for discriminating between malignant and benign breast lesions. • K trans , K ep and MaxSlope were independent predictors of breast malignancy. • qDCE-MRI has a better diagnostic ability than morphology and kinetic analysis. • qDCE-MRI can be used to improve the diagnostic accuracy of breast malignancy.
Entities:
Keywords:
Breast; Diagnosis; Dynamic contrast-enhanced MRI; Magnetic resonance imaging; Neoplasms
Authors: Riham H El Khouli; Katarzyna J Macura; Ihab R Kamel; Michael A Jacobs; David A Bluemke Journal: AJR Am J Roentgenol Date: 2011-12 Impact factor: 3.959
Authors: Ji Youn Kim; Sung Hun Kim; Yun Ju Kim; Bong Joo Kang; Yeong Yi An; A Won Lee; Byung Joo Song; Yong Soo Park; Han Bi Lee Journal: Magn Reson Imaging Date: 2014-08-29 Impact factor: 2.546
Authors: Natsuko Onishi; Meredith Sadinski; Peter Gibbs; Katherine M Gallagher; Mary C Hughes; Eun Sook Ko; Brittany Z Dashevsky; Dattesh D Shanbhag; Maggie M Fung; Theodore M Hunt; Danny F Martinez; Amita Shukla-Dave; Elizabeth A Morris; Elizabeth J Sutton Journal: Eur Radiol Date: 2019-08-29 Impact factor: 5.315
Authors: R Elena Ochoa-Albiztegui; Varadan Sevilimedu; Joao V Horvat; Sunitha B Thakur; Thomas H Helbich; Siegfried Trattnig; Elizabeth A Morris; Jeffrey S Reiner; Katja Pinker Journal: Cancers (Basel) Date: 2020-12-14 Impact factor: 6.639
Authors: George S Karagiannis; Anthony Bianchi; Luis Rivera Sanchez; Kamal Ambadipudi; Min-Hui Cui; Jesus M Anampa; Saeed Asiry; Yarong Wang; Allison S Harney; Jessica M Pastoriza; Yu Lin; Xiaoming Chen; Joan G Jones; David Entenberg; Dana Haddad; Laura J Hodges; Timothy Q Duong; Joseph A Sparano; Maja H Oktay; Craig A Branch; John S Condeelis Journal: NPJ Breast Cancer Date: 2022-09-02
Authors: Natsuko Onishi; Meredith Sadinski; Mary C Hughes; Eun Sook Ko; Peter Gibbs; Katherine M Gallagher; Maggie M Fung; Theodore J Hunt; Danny F Martinez; Amita Shukla-Dave; Elizabeth A Morris; Elizabeth J Sutton Journal: Breast Cancer Res Date: 2020-05-28 Impact factor: 6.466